GENE ONLINE|News &
Opinion
Blog

Breast Cancer
R&D Breast Cancer
Seattle Genetics Enters Breast Cancer Market with Tukysa
2020-04-21
Trials & Approvals Breast Cancer
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Trials & Approvals ATM
Lynparza Meets Primary Endpoint in Phase III PROfound Trial
2019-08-16
Trials & Approvals Breast Cancer
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Trials & Approvals Breast Cancer
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
Trials & Approvals Ovarian Cancer
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Trials & Approvals Alanine Aminotransferase
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Trials & Approvals Breast Cancer
Pfizer’s Talzenna approved for breast cancer treatment
2018-10-25
Trials & Approvals
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Trials & Approvals Breast Cancer
CFDA processes priority review of BGI’s BRCA1/2 gene testing kit
2018-07-11
In-Depth Breast Cancer
PARP inhibitors in cancer – BRCA or no BRCA
2018-07-03
1 2 3 4
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top